So Far This Year, Quoin Pharmaceuticals Ltd. (QNRX) Reached A New High 3 times

As of Friday close, Quoin Pharmaceuticals Ltd.’s (NASDAQ:QNRX) stock was down -$8.77, moving down -62.38 percent to $5.29. The average number of shares traded per day over the past five days has been 12,418,780 shares. 3 times new highs have been achieved over the past 5 days, with a $0.83 gain in that time frame. In the last twenty days, the average volume was 3,133,928, while in the previous 50 days, it was 1,489,588.

Since last month, QNRX stock retreated -25.75%. Shares of the company fell to $3.58 on 08/01/22, the lowest level in the past month. A 52-week high of $444.00 was reached on 01/07/22 after having rallying from a 52-week low of $3.58. Since the beginning of this year, QNRX’s stock price has dropped by -76.75% or -$17.46, and marked a new high 2 times. However, the stock has declined by -98.81% since its 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Financial Health

In the recent quarter, Quoin Pharmaceuticals Ltd.’s quick ratio stood at 3.00, while its current ratio was 3.00, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the recent quarter was 0.06, and the total debt-to-equity ratio was 0.12. Based on annual data, QNRX earned $1.36 million in gross profit and brought in $6.06 million in revenue.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. During the quarter, the company generated -$2.15 million in EBITDA. The liabilities of Quoin Pharmaceuticals Ltd. were 7.56 million at the end of its most recent quarter, and its total debt was $4.57 million.

Technical Picture

This quick technical analysis looks at Quoin Pharmaceuticals Ltd.’s (QNRX) price momentum. With a historical volatility rate of 982.38%, the RSI 9-day stood at 46.09% on 05 August.

With respect to its five-day moving average, the current Quoin Pharmaceuticals Ltd. price is up by +18.64% percent or $0.83. At present, QNRX shares trade -20.15% below its 20-day simple moving average and -66.94% percent below its 100-day simple moving average. However, the stock is currently trading approximately -33.86% below its SMA50 and -97.17% below its SMA200.

Stochastic coefficient K was 38.61% and Stochastic coefficient D was 37.65%, while ATR was 4.92. Given the Stochastic reading of 6.97% for the 14-day period, the RSI (14) reading has been calculated as 47.31%. As of today, the MACD Oscillator reading stands at 5.72, while the 14-day reading stands at 6.43.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]